SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001564590-18-005293
Filing Date
2018-03-12
Accepted
2018-03-12 16:11:34
Documents
77
Period of Report
2017-12-31

Document Format Files

Seq Description Document Type Size
1 10-K kura-10k_20171231.htm 10-K 2482459
2 EX-10.10 kura-ex1010_616.htm EX-10.10 14796
3 EX-10.23 kura-ex1023_180.htm EX-10.23 8986
4 EX-10.24 kura-ex1024_450.htm EX-10.24 75051
5 EX-23.1 kura-ex231_8.htm EX-23.1 4831
6 EX-31.1 kura-ex311_12.htm EX-31.1 19857
7 EX-31.2 kura-ex312_10.htm EX-31.2 19812
8 EX-32.1 kura-ex321_6.htm EX-32.1 9381
9 GRAPHIC g201803121629333053141.jpg GRAPHIC 11315
  Complete submission text file 0001564590-18-005293.txt   8581711

Data Files

Seq Description Document Type Size
10 XBRL INSTANCE DOCUMENT kura-20171231.xml EX-101.INS 1818100
11 XBRL TAXONOMY EXTENSION SCHEMA kura-20171231.xsd EX-101.SCH 62480
12 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE kura-20171231_cal.xml EX-101.CAL 55880
13 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE kura-20171231_def.xml EX-101.DEF 221247
14 XBRL TAXONOMY EXTENSION LABEL LINKBASE kura-20171231_lab.xml EX-101.LAB 483560
15 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE kura-20171231_pre.xml EX-101.PRE 365588
Mailing Address 3033 SCIENCE PARK ROAD, SUITE 220 SAN DIEGO CA 92121
Business Address 3033 SCIENCE PARK ROAD, SUITE 220 SAN DIEGO CA 92121 (858) 500-8800
Kura Oncology, Inc. (Filer) CIK: 0001422143 (see all company filings)

IRS No.: 611547851 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-37620 | Film No.: 18683501
SIC: 2834 Pharmaceutical Preparations